Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P10.01 Anti-migration and anti-invasion effects of curcumin via suppression of fascin expression in glioblastoma cells

View through CrossRef
Abstract BACKGROUND The natural compound Curcumin was known to inhibit migration and invasion of glioblastoma (GBM) cells. Fascin, a kind of actin-binding proteins, is correlated with migration and invasion of GBM cells. The purpose of this study was to investigate anti-migration and anti-invasion effects of Curcumin via suppression of fascin expression in GBM cells. MATERIAL AND METHODS U87 cell line was used as an experimental model of GBM. Fascin was quantified by Western blot analysis. And, the signal transducer and activator of transcription 3 (STAT3), known to play an important role in migration and invasion of tumor cells, were analyzed by sandwich-ELISA. Migration and invasion capacities were assessed by attachment, migration and invasion assays. Cellular morphology was demonstrated by immunofluorescence. RESULTS At various concentrations of curcumin and exposure times, fascin expression decreased. After temporarily exposure to 10μM/L Curcumin during 6 hours as less invasive concentration and time, fascin expression temporarily decreased at 12 hours (18.4%, p=0.024), and since then recovered. And, the change of phosphrylated STAT3 level also reflected the temporarily decreased pattern of fascin expression at 12 hours (19.7%, p=0.010). Attachment, migration, and invasion capacities consistently decreased at 6, 12, and 24 hours. And, immunofluorescence showed the change of shape and the reduction of filopodia formation in cells. CONCLUSION Curcumin is likely to suppress the fascin expression in GBM cells, and this might be a possible mechanism for anti-migration and anti-invasion effects of Curcumin via inhibition of STAT3 phosphorylation.
Title: P10.01 Anti-migration and anti-invasion effects of curcumin via suppression of fascin expression in glioblastoma cells
Description:
Abstract BACKGROUND The natural compound Curcumin was known to inhibit migration and invasion of glioblastoma (GBM) cells.
Fascin, a kind of actin-binding proteins, is correlated with migration and invasion of GBM cells.
The purpose of this study was to investigate anti-migration and anti-invasion effects of Curcumin via suppression of fascin expression in GBM cells.
MATERIAL AND METHODS U87 cell line was used as an experimental model of GBM.
Fascin was quantified by Western blot analysis.
And, the signal transducer and activator of transcription 3 (STAT3), known to play an important role in migration and invasion of tumor cells, were analyzed by sandwich-ELISA.
Migration and invasion capacities were assessed by attachment, migration and invasion assays.
Cellular morphology was demonstrated by immunofluorescence.
RESULTS At various concentrations of curcumin and exposure times, fascin expression decreased.
After temporarily exposure to 10μM/L Curcumin during 6 hours as less invasive concentration and time, fascin expression temporarily decreased at 12 hours (18.
4%, p=0.
024), and since then recovered.
And, the change of phosphrylated STAT3 level also reflected the temporarily decreased pattern of fascin expression at 12 hours (19.
7%, p=0.
010).
Attachment, migration, and invasion capacities consistently decreased at 6, 12, and 24 hours.
And, immunofluorescence showed the change of shape and the reduction of filopodia formation in cells.
CONCLUSION Curcumin is likely to suppress the fascin expression in GBM cells, and this might be a possible mechanism for anti-migration and anti-invasion effects of Curcumin via inhibition of STAT3 phosphorylation.

Related Results

Novel regulation and function of the actin bundling protein Fascin
Novel regulation and function of the actin bundling protein Fascin
<p>The parallel actin filament bundling protein Fascin is a critical protein in both disease and development. Overexpression of Fascin is linked to increased aggressiveness i...
Nghiên cứu bào chế curcumin dạng phytosome và dạng PEG hóa
Nghiên cứu bào chế curcumin dạng phytosome và dạng PEG hóa
Curcumin có nhiều tác dụng dược lý quan trọng nhưng chưa được ứng dụng nhiều trên lâm sàng do sinh khả dụng thấp. Phytosome curcumin và PEG-CUR được nghiên cứu để tăng sinh khả dụn...
Abstract 1772: Circadian control of cell death in glioma cells treated with curcumin
Abstract 1772: Circadian control of cell death in glioma cells treated with curcumin
Abstract Treatments based on the phytochemical curcumin have much potential for use in cancer treatments because of their effects on a wide variety of biological pat...
Synthesis, characterization and evaluation of antibacterial activity of copper(II)-curcumin complex against staphylococcus aureus
Synthesis, characterization and evaluation of antibacterial activity of copper(II)-curcumin complex against staphylococcus aureus
Curcumin, a phytochemical from turmeric, and its derivatives have been extensively investigated from both chemical and biological strategies. However, the main problem encountered ...
Abstract A76: Curcumin inhibits head and neck squamous cell carcinoma (HNSCC) migration
Abstract A76: Curcumin inhibits head and neck squamous cell carcinoma (HNSCC) migration
Abstract Purpose: Curcumin has been shown to inhibit HNSCC cell proliferation through the AKT/MTOR pathway. We wanted to study the biological effects of curcumin-ind...
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
Abstract Glioblastoma is the most common malignant brain tumor in adults. Cellular plasticity and the poorly differentiated features result in a ...
Abstract 1739: Reversal of lenvatinib resistance by curcumin via EGFR signaling pathway in hepatocellular carcinoma
Abstract 1739: Reversal of lenvatinib resistance by curcumin via EGFR signaling pathway in hepatocellular carcinoma
Abstract Background: Patients with unresectable advanced hepatocellular carcinoma (HCC) are often treated with systemic therapies, and lenvatinib is currently used a...

Back to Top